NTRA Quote, Financials, Valuation and Earnings

Guardant Health, Inc. has a net margin of -14.78% compared to Natera, Inc.'s net margin of -34.97%. Natera, Inc.'s return on equity of -26.6% beat Guardant Health, Inc.'s return on equity of -8518.58%.

Natera, Inc. has a consensus price target of $257.20, signalling upside risk potential of 11.29%. On the other hand Guardant Health, Inc. has an analysts' consensus of $125.24 which suggests that it could grow by 9%. Given that Natera, Inc. has higher upside potential than Guardant Health, Inc., analysts believe Natera, Inc. is more attractive than Guardant Health, Inc..

Natera, Inc. has a beta of 1.636, which suggesting that the stock is 63.611% more volatile than S&P 500. In comparison Guardant Health, Inc. has a beta of 1.631, suggesting its more volatile than the S&P 500 by 63.129%.

Natera, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Guardant Health, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Natera, Inc. pays -- of its earnings as a dividend. Guardant Health, Inc. pays out -- of its earnings as a dividend.

Natera, Inc. quarterly revenues are $592.2M, which are larger than Guardant Health, Inc. quarterly revenues of $265.2M. Natera, Inc.'s net income of -$87.5M is higher than Guardant Health, Inc.'s net income of -$92.7M. Notably, Natera, Inc.'s price-to-earnings ratio is -- while Guardant Health, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Natera, Inc. is 14.73x versus 15.80x for Guardant Health, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Illumina, Inc. has a net margin of -14.78% compared to Natera, Inc.'s net margin of 13.85%. Natera, Inc.'s return on equity of -26.6% beat Illumina, Inc.'s return on equity of 30.55%.

Natera, Inc. has a consensus price target of $257.20, signalling upside risk potential of 11.29%. On the other hand Illumina, Inc. has an analysts' consensus of $135.94 which suggests that it could fall by -3.68%. Given that Natera, Inc. has higher upside potential than Illumina, Inc., analysts believe Natera, Inc. is more attractive than Illumina, Inc..

Natera, Inc. has a beta of 1.636, which suggesting that the stock is 63.611% more volatile than S&P 500. In comparison Illumina, Inc. has a beta of 1.450, suggesting its more volatile than the S&P 500 by 44.964%.

Natera, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Illumina, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Natera, Inc. pays -- of its earnings as a dividend. Illumina, Inc. pays out -- of its earnings as a dividend.

Natera, Inc. quarterly revenues are $592.2M, which are smaller than Illumina, Inc. quarterly revenues of $1.1B. Natera, Inc.'s net income of -$87.5M is lower than Illumina, Inc.'s net income of $150M. Notably, Natera, Inc.'s price-to-earnings ratio is -- while Illumina, Inc.'s PE ratio is 31.62x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Natera, Inc. is 14.73x versus 5.19x for Illumina, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Mettler-Toledo International, Inc. has a net margin of -14.78% compared to Natera, Inc.'s net margin of 21.12%. Natera, Inc.'s return on equity of -26.6% beat Mettler-Toledo International, Inc.'s return on equity of --.

Natera, Inc. has a consensus price target of $257.20, signalling upside risk potential of 11.29%. On the other hand Mettler-Toledo International, Inc. has an analysts' consensus of $1,504.15 which suggests that it could grow by 8.56%. Given that Natera, Inc. has higher upside potential than Mettler-Toledo International, Inc., analysts believe Natera, Inc. is more attractive than Mettler-Toledo International, Inc..

Natera, Inc. has a beta of 1.636, which suggesting that the stock is 63.611% more volatile than S&P 500. In comparison Mettler-Toledo International, Inc. has a beta of 1.424, suggesting its more volatile than the S&P 500 by 42.389%.

Natera, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Mettler-Toledo International, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Natera, Inc. pays -- of its earnings as a dividend. Mettler-Toledo International, Inc. pays out -- of its earnings as a dividend.

Natera, Inc. quarterly revenues are $592.2M, which are smaller than Mettler-Toledo International, Inc. quarterly revenues of $1B. Natera, Inc.'s net income of -$87.5M is lower than Mettler-Toledo International, Inc.'s net income of $217.5M. Notably, Natera, Inc.'s price-to-earnings ratio is -- while Mettler-Toledo International, Inc.'s PE ratio is 34.56x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Natera, Inc. is 14.73x versus 7.33x for Mettler-Toledo International, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

GeneDx Holdings Corp. has a net margin of -14.78% compared to Natera, Inc.'s net margin of -6.54%. Natera, Inc.'s return on equity of -26.6% beat GeneDx Holdings Corp.'s return on equity of 0.82%.

Natera, Inc. has a consensus price target of $257.20, signalling upside risk potential of 11.29%. On the other hand GeneDx Holdings Corp. has an analysts' consensus of $170.00 which suggests that it could grow by 71.7%. Given that GeneDx Holdings Corp. has higher upside potential than Natera, Inc., analysts believe GeneDx Holdings Corp. is more attractive than Natera, Inc..

Natera, Inc. has a beta of 1.636, which suggesting that the stock is 63.611% more volatile than S&P 500. In comparison GeneDx Holdings Corp. has a beta of 2.078, suggesting its more volatile than the S&P 500 by 107.756%.

Natera, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. GeneDx Holdings Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Natera, Inc. pays -- of its earnings as a dividend. GeneDx Holdings Corp. pays out -- of its earnings as a dividend.

Natera, Inc. quarterly revenues are $592.2M, which are larger than GeneDx Holdings Corp. quarterly revenues of $116.7M. Natera, Inc.'s net income of -$87.5M is lower than GeneDx Holdings Corp.'s net income of -$7.6M. Notably, Natera, Inc.'s price-to-earnings ratio is -- while GeneDx Holdings Corp.'s PE ratio is 1,641.96x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Natera, Inc. is 14.73x versus 7.06x for GeneDx Holdings Corp.. Usually stocks with elevated PS ratios are considered overvalued.